enVVeno Medical Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,658,932.8% | – | – | – | – | – | – | – | – | – | – | |
| – | +93,408.5% | +20.5% | -7.9% | -4.2% | +197.3% | -3.2% | +18.0% | +15.9% | +4.0% | -3.3% | -7.4% | |
| – | – | – | -41.8% | +118.9% | -51.0% | -6.4% | +580.8% | +49.9% | -42.2% | -20.3% | -17.4% | |
| – | – | – | – | -12.0% | +169.0% | -54.5% | +715.6% | +59.1% | – | – | – | |
| – | -1,081,392,100.0% | – | – | -152.9% | – | +896.9% | -272.1% | – | – | – | -236.6% | |
| – | +8,384.5% | +14,160.2% | -97.1% | +13.6% | +2,829.4% | -50.5% | +104.1% | -68.8% | -71.3% | +12.1% | -86.5% | |
| – | +251,260.1% | +380.2% | – | -107.5% | +2,829.4% | -50.5% | +104.1% | +9,289.7% | -77.2% | – | +1,087.7% | |
| – | – | – | – | -34.2% | -85.0% | +0.0% | -100.0% | – | – | – | – | |
| – | – | -37.6% | +79.5% | +122.5% | -37.6% | +167.4% | +282.1% | -100.0% | – | -47.1% | -92.5% | |
| – | +4,948,633.0% | -200.1% | – | +12,476.5% | -123.4% | – | +528.9% | -210.5% | – | – | – | |
| – | -2,225,593.1% | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.